Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Harding

Showing results (881-890 of 946) with videos related to

Pageof 95
Sort By:
JAMA Oncology|November 20, 2025
Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01Shubham Pant, Jia Fan, Do-Youn Oh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 2, 2017
Patient perspectives on ipilimumab across the melanoma treatment trajectoryElyse Shuk, Alexander N Shoushtari, Jason Luke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2022
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for InterventionNicolas A Giraldo, Esther Drill, Baby A Satravada, et al.
Cancer|August 20, 2021
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 studyJames J Harding, Tsai-Sheng Yang, Yen-Yang Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2024
Poly ADP-ribose signaling is dysregulated in Huntington diseaseTamara Maiuri, Carlos Barba Bazan, Rachel J Harding, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
JCO Precision Oncology|February 23, 2024
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic CholangiocarcinomaSarah M McIntyre, William A Preston, Henry Walch, et al.
JCO Precision Oncology|September 28, 2023
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular CarcinomaDarren Cowzer, Jessica B White, Joanne F Chou, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Genome-wide association studies reveal novel loci associated with pyrethroid and organophosphate resistance in <i>Anopheles gambiae</i> s.lEric R Lucas, Sanjay C Nagi, Alexander Egyir-Yawson, et al.
Pageof 95

Showing results (881-890 of 946) with videos related to

Sort By:
Pageof 95
JAMA Oncology|November 20, 2025
Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01Shubham Pant, Jia Fan, Do-Youn Oh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 2, 2017
Patient perspectives on ipilimumab across the melanoma treatment trajectoryElyse Shuk, Alexander N Shoushtari, Jason Luke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2022
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for InterventionNicolas A Giraldo, Esther Drill, Baby A Satravada, et al.
Cancer|August 20, 2021
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 studyJames J Harding, Tsai-Sheng Yang, Yen-Yang Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2024
Poly ADP-ribose signaling is dysregulated in Huntington diseaseTamara Maiuri, Carlos Barba Bazan, Rachel J Harding, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
JCO Precision Oncology|February 23, 2024
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic CholangiocarcinomaSarah M McIntyre, William A Preston, Henry Walch, et al.
JCO Precision Oncology|September 28, 2023
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular CarcinomaDarren Cowzer, Jessica B White, Joanne F Chou, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Genome-wide association studies reveal novel loci associated with pyrethroid and organophosphate resistance in <i>Anopheles gambiae</i> s.lEric R Lucas, Sanjay C Nagi, Alexander Egyir-Yawson, et al.
Pageof 95